GC has been a true pioneer in biomedicine in South Korea over the last five decades through its development of innovative plasma-derived products, vaccines, and a host of other pharmaceuticals at a time when such modern medicines were hardly known in the country. Based on this venturesome spirit and passion to drive healthcare innovation, we are facing our next Great Challenge: Introducing the first and only commercial-scale plasma fractionation facility in Canada.
With a dynamic start-up environment, we are dedicated to implement an innovative bio-manufacturing process in Canada, reinforced with over 50 years of international bio-pharmaceutical R&D and production experience.
Our Great Commitment is to empower ambitious life science professionals who share the same adventurous spirit, and passion to improving the health of humanity, with state-of-the-art biotechnologies and global training to develop into Canada’s very own plasma fractionation Pioneers.
Challenge and innovation are the driving force behind the growth of the GC family and the establishment of GCBT. GC would not have achieved its success by embracing the Great Challenge and developing new drugs and expanding their portfolio of products into different countries throughout the world.
Our strength lies in our ability to collaborate, communicate, and work together towards common goals. We are committed to bringing out the best in each other as we work toward achieving our mission and vision every day.
These two values take root in our work ethic and passion. Creating a smart and efficient work culture that strives to achieve its goal is key to our success.
To learn more about the career opportunities that await you at GCBT or to apply to be part of our team of #GCBTpioneers, please send us your resume and cover letter at email@example.com or view the current job opportunities listed below.